{"id":342317,"date":"2025-08-20T17:38:44","date_gmt":"2025-08-20T17:38:44","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-astrazeneca\/"},"modified":"2025-08-20T17:38:44","modified_gmt":"2025-08-20T17:38:44","slug":"how-to-buy-astrazeneca","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/","title":{"rendered":"AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; AstraZeneca PLC (AZN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-342317","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r - AstraZeneca PLC (AZN) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r - AstraZeneca PLC (AZN) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"AstraZeneca PLC (AZN) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. Bu ila\u00e7 devi i\u00e7in g\u00fcncel fiyat trendlerini, b\u00fcy\u00fcme kataliz\u00f6rlerini ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"AstraZeneca PLC (AZN) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. Bu ila\u00e7 devi i\u00e7in g\u00fcncel fiyat trendlerini, b\u00fcy\u00fcme kataliz\u00f6rlerini ve ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini ke\u015ffedin."},"intro":"D\u00fcnyan\u0131n \u00f6nde gelen ila\u00e7 \u015firketlerinden birine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? AstraZeneca PLC (AZN), yenilik\u00e7ili\u011fi istikrarla birle\u015ftiriyor\u2014hem yeni hem de deneyimli yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Onkoloji, kardiyovask\u00fcler bak\u0131m ve solunum t\u0131bb\u0131nda \u00e7\u0131\u011f\u0131r a\u00e7an tedavilerle, bu \u015firket d\u00fcnya \u00e7ap\u0131nda milyonlarca hayat\u0131 etkiliyor. Mevcut hisse performans\u0131ndan stratejik giri\u015f noktalar\u0131na ve neden 2025'in benzersiz yat\u0131r\u0131m f\u0131rsatlar\u0131 sundu\u011funa kadar her \u015feyi ke\u015ffedece\u011fiz.","intro_source":{"label":"Intro","type":"text","formatted_value":"D\u00fcnyan\u0131n \u00f6nde gelen ila\u00e7 \u015firketlerinden birine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? AstraZeneca PLC (AZN), yenilik\u00e7ili\u011fi istikrarla birle\u015ftiriyor\u2014hem yeni hem de deneyimli yat\u0131r\u0131mc\u0131lar i\u00e7in m\u00fckemmel. Onkoloji, kardiyovask\u00fcler bak\u0131m ve solunum t\u0131bb\u0131nda \u00e7\u0131\u011f\u0131r a\u00e7an tedavilerle, bu \u015firket d\u00fcnya \u00e7ap\u0131nda milyonlarca hayat\u0131 etkiliyor. Mevcut hisse performans\u0131ndan stratejik giri\u015f noktalar\u0131na ve neden 2025'in benzersiz yat\u0131r\u0131m f\u0131rsatlar\u0131 sundu\u011funa kadar her \u015feyi ke\u015ffedece\u011fiz."},"body_html":"<h2>\ud83d\udcc8 AstraZeneca Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla, AstraZeneca PLC (AZN) NASDAQ borsas\u0131nda <strong>79,54 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>6 Kas\u0131m 2025<\/strong> kesinlikle kritik\u2014bu tarihte AstraZeneca \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketleri yarat\u0131r ve ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar bundan faydalanabilir.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 AZN Hissesini Nas\u0131l Hareket Ettirir<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>29 Tem 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>78,20 $<\/td><td>%1,7 Art\u0131\u015f (beklentilerle uyumlu)<\/td><\/tr> <tr><td>29 Nis 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>72,50 $<\/td><td>%6,9 Art\u0131\u015f (g\u00fc\u00e7l\u00fc performans)<\/td><\/tr> <tr><td>5 \u015eub 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>70,80 $<\/td><td>%4,2 Art\u0131\u015f (y\u00f6nlendirme y\u00fckseltildi)<\/td><\/tr> <tr><td>7 Kas 2024<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>68,40 $<\/td><td>%3,1 Art\u0131\u015f (pipeline ilerlemesi)<\/td><\/tr> <tr><td>8 A\u011fu 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>66,90 $<\/td><td>%2,2 Art\u0131\u015f (istikrarl\u0131 b\u00fcy\u00fcme)<\/td><\/tr> <tr><td>9 May 2024<\/td><td>\u00dcr\u00fcn Lansman\u0131<\/td><td>65,20 $<\/td><td>%2,6 Art\u0131\u015f (pazar geni\u015flemesi)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Nisan 2025'teki %6,9'luk pozitif kazan\u00e7 s\u00fcrprizi gibi olumlu sonu\u00e7lar hemen al\u0131m f\u0131rsatlar\u0131 yarat\u0131r. Beklentilerin kar\u015f\u0131lanmas\u0131 genellikle m\u00fctevaz\u0131 kazan\u00e7larla sonu\u00e7lan\u0131rken, beklentilerin alt\u0131nda kalan sonu\u00e7lar ge\u00e7ici d\u00fc\u015f\u00fc\u015flere neden olur; ancak AstraZeneca'n\u0131n g\u00fc\u00e7l\u00fc temelleri sayesinde bu d\u00fc\u015f\u00fc\u015fler genellikle h\u0131zla toparlan\u0131r.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h2> <p>AstraZeneca hisseleri bu d\u00f6nemde yakla\u015f\u0131k <strong>%15<\/strong> de\u011fer kazanarak dikkat \u00e7ekici bir diren\u00e7 g\u00f6sterdi:<\/p> <ul> <li><strong>Mart 2025<\/strong>: 69,20 $ (k\u0131\u015f sonras\u0131 konsolidasyon)<\/li> <li><strong>Nisan 2025<\/strong>: 77,50 $ (1. \u00e7eyrek kazan\u00e7 art\u0131\u015f\u0131)<\/li> <li><strong>May\u0131s 2025<\/strong>: 75,80 $ (kar realizasyonu d\u00f6nemi)<\/li> <li><strong>Haziran 2025<\/strong>: 78,90 $ (pipeline iyimserli\u011fi)<\/li> <li><strong>Temmuz 2025<\/strong>: 79,10 $ (istikrarl\u0131 birikim)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 79,54 $ (mevcut istikrar)<\/li> <\/ul> <p><strong>Bu istikrarl\u0131 y\u00fckseli\u015fin nedeni nedir?<\/strong><\/p> <ul> <li>T\u00fcm b\u00f6lgelerde \u00e7ift haneli gelir b\u00fcy\u00fcmesi<\/li> <li>2025'in ilk yar\u0131s\u0131nda 12 ba\u015far\u0131l\u0131 Faz III deneme sonu\u00e7lar\u0131<\/li> <li>50 milyar $ tutar\u0131nda stratejik ABD \u00fcretim yat\u0131r\u0131m\u0131 duyurusu<\/li> <li>B\u00fcy\u00fck pazarlarda 19 yeni d\u00fczenleyici onay<\/li> <\/ul> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p><strong>2025 Y\u0131l Sonu<\/strong>: 86-92 $ (4. \u00e7eyrek kazan\u00e7 ivmesi + tatil sezonu g\u00fcc\u00fc) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br\/> <strong>2026<\/strong>: 95-105 $ (\u00fcretim geni\u015flemesinin faydalar\u0131 + yeni ila\u00e7 lansmanlar\u0131)<br\/> <strong>2028<\/strong>: 120-135 $ (80 milyar $ gelir hedefi ilerlemesi + pazar hakimiyeti)<br\/> <strong>2030<\/strong>: 150-170 $ (k\u00fcresel sa\u011fl\u0131k hizmetleri geni\u015flemesi + ya\u015flanan n\u00fcfus talebi)<\/p> <p><strong>Sonu\u00e7<\/strong>: <strong>Uzun vadeli birikim<\/strong> i\u00e7in ideal. K\u0131sa vadeli yat\u0131r\u0131mc\u0131lar 6 Kas\u0131m civar\u0131ndaki kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015fleri izlemeli.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>D\u00fczenleyici inceleme<\/strong>: \u00c7in'deki uyum iddialar\u0131na y\u00f6nelik soru\u015fturmalar Asya gelirlerini etkileyebilir (<a href=\"https:\/\/www.gurufocus.com\/news\/2647117\/astrazeneca-faces-legal-challenges-amidst-chinese-regulatory-probe\">GuruFocus Raporu<\/a>)<\/li> <li><strong>Hukuki zorluklar<\/strong>: ABD mahkemelerindeki devam eden menkul k\u0131ymet davalar\u0131 belirsizlik yarat\u0131yor<\/li> <li><strong>Fiyat bask\u0131lar\u0131<\/strong>: Medicare ila\u00e7 fiyat m\u00fczakereleri ABD pazar marjlar\u0131n\u0131 etkiliyor<\/li> <li><strong>Pipeline ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Y\u00fcksek Ar-Ge maliyetleri klinik deneme hayal k\u0131r\u0131kl\u0131klar\u0131n\u0131 ciddi \u015fekilde etkiler<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Devasa ABD yat\u0131r\u0131m\u0131<\/strong>: 2030'a kadar 50 milyar $ \u00fcretim geni\u015flemesi (<a href=\"https:\/\/www.ainvest.com\/news\/astrazeneca-50b-expansion-strategic-manufacturing-localization-revenue-growth-catalysts-2507\/\">AInvest Analizi<\/a>)<\/li> <li><strong>Pipeline patlamas\u0131<\/strong>: Ge\u00e7 a\u015fama geli\u015ftirmede 21 yeni molek\u00fcler varl\u0131k, 7'si yak\u0131nda Faz III sonu\u00e7lar\u0131yla (<a href=\"https:\/\/www.pharmaceutical-technology.com\/news\/jp-morgan-2025-astrazeneca-promises-a-catalyst-rich-year-ahead\/\">Pharmaceutical Technology<\/a>)<\/li> <li><strong>Stratejik sat\u0131n almalar<\/strong>: Onkoloji yeteneklerini art\u0131ran 2,7 milyar $ de\u011ferinde EsoBiotec al\u0131m\u0131<\/li> <li><strong>Gelir ivmesi<\/strong>: %12 Y\u0131ll\u0131k 2. \u00e7eyrek b\u00fcy\u00fcme ve y\u00fcksek tek haneli geni\u015fleme i\u00e7in y\u00f6nlendirme teyidi<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in haftal\u0131k sabit miktarlarla dolar maliyeti ortalamas\u0131 yap\u0131n<\/li> <li><strong>Kazan\u00e7 uyar\u0131lar\u0131 kurun<\/strong>: AZN'yi 6 Kas\u0131m civar\u0131nda izleyin; kazan\u00e7 sonras\u0131 %3-5 d\u00fc\u015f\u00fc\u015flerde al\u0131m yap\u0131n<\/li> <li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: B\u00fcy\u00fcme e\u011filimi g\u00f6z \u00f6n\u00fcnde bulundurularak sadece 2-3 y\u0131l tutabilece\u011finiz miktar\u0131 ay\u0131r\u0131n<\/li> <li><strong>Esprili yakla\u015f\u0131m<\/strong>: \"AZN ticareti ila\u00e7 almak gibidir\u2014panik anlar\u0131nda doz atlay\u0131n ama uzun vadeli sa\u011fl\u0131k i\u00e7in tutarl\u0131 kal\u0131n!\"<\/li> <\/ol> <h2>\u2705 AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeli hisseleri ve rekabet\u00e7i \u00fccretleri sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Y\u00f6netilebilir miktarlarla ba\u015flay\u0131n\u2014k\u0131smi hisseler i\u00e7in 100 $ bile yeterlidir<\/td><\/tr> <tr><td>3<\/td><td>\"AZN\" sembol\u00fcn\u00fc aray\u0131n<\/td><td>Sadece \"AstraZeneca\" de\u011fil, tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Limit emirleri a\u015f\u0131r\u0131 \u00f6deme yapmay\u0131 \u00f6nler; maksimum fiyat\u0131 80,50 $ gibi belirleyin<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon oranlar\u0131n\u0131 kontrol edin\u2014i\u015flem ba\u015f\u0131na %0,5'in alt\u0131nda hedefleyin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonu izleyin<\/td><td>Kazan\u00e7 tarihleri ve \u00f6nemli haberler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <tr><td>7<\/td><td>Temett\u00fcleri yeniden yat\u0131r\u0131n<\/td><td>AZN'nin %1,90 verimi zamanla g\u00fczelce bile\u015fik getiri sa\u011flar<\/td><\/tr> <tr><td>8<\/td><td>\u00dc\u00e7 ayda bir g\u00f6zden ge\u00e7irin<\/td><td>\u015eirket kazan\u00e7 raporlar\u0131na kar\u015f\u0131 performans\u0131 de\u011ferlendirin<\/td><\/tr> <tr><td>9<\/td><td>Stratejiyi ayarlay\u0131n<\/td><td>Kan\u0131tlanm\u0131\u015f b\u00fcy\u00fcme onay\u0131yla pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc art\u0131r\u0131n<\/td><\/tr> <tr><td>10<\/td><td>Uzun vadeli tutun<\/td><td>\u0130la\u00e7 hisseleri zamanlamadan \u00e7ok sabr\u0131 \u00f6d\u00fcllendirir<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Pocket Option, yeni ba\u015flayanlar i\u00e7in hisse senedi eri\u015fimini devrim niteli\u011finde de\u011fi\u015ftiriyor:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong>\u2014ger\u00e7ek para ile stratejileri \u00f6nemli risk olmadan test edin<\/li> <li><strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong>\u2014herhangi bir resmi kimlik y\u00fckleyin ve hemen ticarete ba\u015flay\u0131n<\/li> <li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong>\u2014kripto paralar, e-c\u00fczdanlar, banka kartlar\u0131 ve yerel se\u00e7enekler<\/li> <li><strong>K\u0131smi hisse al\u0131m\u0131 m\u00fcmk\u00fcn<\/strong>\u2014k\u00fc\u00e7\u00fck sermayeyle bile AZN par\u00e7alar\u0131 sat\u0131n al\u0131n<\/li> <li><strong>Ger\u00e7ek zamanl\u0131 piyasa verisi<\/strong>\u2014karma\u015f\u0131kl\u0131k olmadan profesyonel ara\u00e7lar<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, AstraZeneca PLC (AZN) hisselerine ilk yat\u0131r\u0131m\u0131n\u0131z\u0131 basit ve \u00f6\u011fretici hale getirir.<\/p> <h2>\ud83c\udf0d 2025'te AstraZeneca: \u0130la\u00e7 Devi<\/h2> <p>AstraZeneca, 246 milyar $'\u0131 a\u015fan piyasa de\u011feriyle bir\u00e7ok terap\u00f6tik alanda liderdir. Geleneksel ila\u00e7lar\u0131n \u00f6tesinde, \u015firket yenilik\u00e7i h\u00fccre terapileri ve yapay zeka destekli ila\u00e7 geli\u015ftirmede \u00f6nc\u00fcd\u00fcr. \u0130ngiliz-\u0130sve\u00e7li dev, 130'dan fazla \u00fclkede faaliyet g\u00f6stermekte ve y\u0131lda yakla\u015f\u0131k 11 milyar $ Ar-Ge harcamas\u0131 yapmaktad\u0131r.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: AstraZeneca'n\u0131n yeni Virginia \u00fcretim tesisi, ila\u00e7 \u00fcretiminde yapay zeka ve robotik kullanacak\u2014bu, \u015firketin d\u00fcnya \u00e7ap\u0131ndaki en b\u00fcy\u00fck tek yat\u0131r\u0131m\u0131 olacak ve \u00e7al\u0131\u015fanlar\u0131n farkl\u0131 katlar i\u00e7in haftal\u0131k olarak koku se\u00e7ti\u011fi parf\u00fcm p\u00fcsk\u00fcrten asans\u00f6rlere sahip olacak!<\/p> <p>Daha fazla e\u011fitim i\u00e7eri\u011fi ve piyasa analizleri i\u00e7in <a href=\"\/blog\">Pocket Option blog<\/a> sayfam\u0131z\u0131 ziyaret edin; karma\u015f\u0131k yat\u0131r\u0131m kavramlar\u0131n\u0131 uygulanabilir stratejilere d\u00f6n\u00fc\u015ft\u00fcr\u00fcyoruz.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 AstraZeneca Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla, AstraZeneca PLC (AZN) NASDAQ borsas\u0131nda <strong>79,54 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>6 Kas\u0131m 2025<\/strong> kesinlikle kritik\u2014bu tarihte AstraZeneca \u00fc\u00e7\u00fcnc\u00fc \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu a\u00e7\u0131klamalar \u00f6nemli fiyat hareketleri yarat\u0131r ve ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar bundan faydalanabilir.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 AZN Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>29 Tem 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>78,20 $<\/td>\n<td>%1,7 Art\u0131\u015f (beklentilerle uyumlu)<\/td>\n<\/tr>\n<tr>\n<td>29 Nis 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>72,50 $<\/td>\n<td>%6,9 Art\u0131\u015f (g\u00fc\u00e7l\u00fc performans)<\/td>\n<\/tr>\n<tr>\n<td>5 \u015eub 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>70,80 $<\/td>\n<td>%4,2 Art\u0131\u015f (y\u00f6nlendirme y\u00fckseltildi)<\/td>\n<\/tr>\n<tr>\n<td>7 Kas 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>68,40 $<\/td>\n<td>%3,1 Art\u0131\u015f (pipeline ilerlemesi)<\/td>\n<\/tr>\n<tr>\n<td>8 A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>66,90 $<\/td>\n<td>%2,2 Art\u0131\u015f (istikrarl\u0131 b\u00fcy\u00fcme)<\/td>\n<\/tr>\n<tr>\n<td>9 May 2024<\/td>\n<td>\u00dcr\u00fcn Lansman\u0131<\/td>\n<td>65,20 $<\/td>\n<td>%2,6 Art\u0131\u015f (pazar geni\u015flemesi)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Nisan 2025&#8217;teki %6,9&#8217;luk pozitif kazan\u00e7 s\u00fcrprizi gibi olumlu sonu\u00e7lar hemen al\u0131m f\u0131rsatlar\u0131 yarat\u0131r. Beklentilerin kar\u015f\u0131lanmas\u0131 genellikle m\u00fctevaz\u0131 kazan\u00e7larla sonu\u00e7lan\u0131rken, beklentilerin alt\u0131nda kalan sonu\u00e7lar ge\u00e7ici d\u00fc\u015f\u00fc\u015flere neden olur; ancak AstraZeneca&#8217;n\u0131n g\u00fc\u00e7l\u00fc temelleri sayesinde bu d\u00fc\u015f\u00fc\u015fler genellikle h\u0131zla toparlan\u0131r.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-A\u011fustos 2025)<\/h2>\n<p>AstraZeneca hisseleri bu d\u00f6nemde yakla\u015f\u0131k <strong>%15<\/strong> de\u011fer kazanarak dikkat \u00e7ekici bir diren\u00e7 g\u00f6sterdi:<\/p>\n<ul>\n<li><strong>Mart 2025<\/strong>: 69,20 $ (k\u0131\u015f sonras\u0131 konsolidasyon)<\/li>\n<li><strong>Nisan 2025<\/strong>: 77,50 $ (1. \u00e7eyrek kazan\u00e7 art\u0131\u015f\u0131)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 75,80 $ (kar realizasyonu d\u00f6nemi)<\/li>\n<li><strong>Haziran 2025<\/strong>: 78,90 $ (pipeline iyimserli\u011fi)<\/li>\n<li><strong>Temmuz 2025<\/strong>: 79,10 $ (istikrarl\u0131 birikim)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 79,54 $ (mevcut istikrar)<\/li>\n<\/ul>\n<p><strong>Bu istikrarl\u0131 y\u00fckseli\u015fin nedeni nedir?<\/strong><\/p>\n<ul>\n<li>T\u00fcm b\u00f6lgelerde \u00e7ift haneli gelir b\u00fcy\u00fcmesi<\/li>\n<li>2025&#8217;in ilk yar\u0131s\u0131nda 12 ba\u015far\u0131l\u0131 Faz III deneme sonu\u00e7lar\u0131<\/li>\n<li>50 milyar $ tutar\u0131nda stratejik ABD \u00fcretim yat\u0131r\u0131m\u0131 duyurusu<\/li>\n<li>B\u00fcy\u00fck pazarlarda 19 yeni d\u00fczenleyici onay<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 86-92 $ (4. \u00e7eyrek kazan\u00e7 ivmesi + tatil sezonu g\u00fcc\u00fc) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br \/> <strong>2026<\/strong>: 95-105 $ (\u00fcretim geni\u015flemesinin faydalar\u0131 + yeni ila\u00e7 lansmanlar\u0131)<br \/> <strong>2028<\/strong>: 120-135 $ (80 milyar $ gelir hedefi ilerlemesi + pazar hakimiyeti)<br \/> <strong>2030<\/strong>: 150-170 $ (k\u00fcresel sa\u011fl\u0131k hizmetleri geni\u015flemesi + ya\u015flanan n\u00fcfus talebi)<\/p>\n<p><strong>Sonu\u00e7<\/strong>: <strong>Uzun vadeli birikim<\/strong> i\u00e7in ideal. K\u0131sa vadeli yat\u0131r\u0131mc\u0131lar 6 Kas\u0131m civar\u0131ndaki kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015fleri izlemeli.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>D\u00fczenleyici inceleme<\/strong>: \u00c7in&#8217;deki uyum iddialar\u0131na y\u00f6nelik soru\u015fturmalar Asya gelirlerini etkileyebilir (<a href=\"https:\/\/www.gurufocus.com\/news\/2647117\/astrazeneca-faces-legal-challenges-amidst-chinese-regulatory-probe\">GuruFocus Raporu<\/a>)<\/li>\n<li><strong>Hukuki zorluklar<\/strong>: ABD mahkemelerindeki devam eden menkul k\u0131ymet davalar\u0131 belirsizlik yarat\u0131yor<\/li>\n<li><strong>Fiyat bask\u0131lar\u0131<\/strong>: Medicare ila\u00e7 fiyat m\u00fczakereleri ABD pazar marjlar\u0131n\u0131 etkiliyor<\/li>\n<li><strong>Pipeline ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Y\u00fcksek Ar-Ge maliyetleri klinik deneme hayal k\u0131r\u0131kl\u0131klar\u0131n\u0131 ciddi \u015fekilde etkiler<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Devasa ABD yat\u0131r\u0131m\u0131<\/strong>: 2030&#8217;a kadar 50 milyar $ \u00fcretim geni\u015flemesi (<a href=\"https:\/\/www.ainvest.com\/news\/astrazeneca-50b-expansion-strategic-manufacturing-localization-revenue-growth-catalysts-2507\/\">AInvest Analizi<\/a>)<\/li>\n<li><strong>Pipeline patlamas\u0131<\/strong>: Ge\u00e7 a\u015fama geli\u015ftirmede 21 yeni molek\u00fcler varl\u0131k, 7&#8217;si yak\u0131nda Faz III sonu\u00e7lar\u0131yla (<a href=\"https:\/\/www.pharmaceutical-technology.com\/news\/jp-morgan-2025-astrazeneca-promises-a-catalyst-rich-year-ahead\/\">Pharmaceutical Technology<\/a>)<\/li>\n<li><strong>Stratejik sat\u0131n almalar<\/strong>: Onkoloji yeteneklerini art\u0131ran 2,7 milyar $ de\u011ferinde EsoBiotec al\u0131m\u0131<\/li>\n<li><strong>Gelir ivmesi<\/strong>: %12 Y\u0131ll\u0131k 2. \u00e7eyrek b\u00fcy\u00fcme ve y\u00fcksek tek haneli geni\u015fleme i\u00e7in y\u00f6nlendirme teyidi<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in haftal\u0131k sabit miktarlarla dolar maliyeti ortalamas\u0131 yap\u0131n<\/li>\n<li><strong>Kazan\u00e7 uyar\u0131lar\u0131 kurun<\/strong>: AZN&#8217;yi 6 Kas\u0131m civar\u0131nda izleyin; kazan\u00e7 sonras\u0131 %3-5 d\u00fc\u015f\u00fc\u015flerde al\u0131m yap\u0131n<\/li>\n<li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: B\u00fcy\u00fcme e\u011filimi g\u00f6z \u00f6n\u00fcnde bulundurularak sadece 2-3 y\u0131l tutabilece\u011finiz miktar\u0131 ay\u0131r\u0131n<\/li>\n<li><strong>Esprili yakla\u015f\u0131m<\/strong>: &#8220;AZN ticareti ila\u00e7 almak gibidir\u2014panik anlar\u0131nda doz atlay\u0131n ama uzun vadeli sa\u011fl\u0131k i\u00e7in tutarl\u0131 kal\u0131n!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeli hisseleri ve rekabet\u00e7i \u00fccretleri sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Y\u00f6netilebilir miktarlarla ba\u015flay\u0131n\u2014k\u0131smi hisseler i\u00e7in 100 $ bile yeterlidir<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;AZN&#8221; sembol\u00fcn\u00fc aray\u0131n<\/td>\n<td>Sadece &#8220;AstraZeneca&#8221; de\u011fil, tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limit emirleri a\u015f\u0131r\u0131 \u00f6deme yapmay\u0131 \u00f6nler; maksimum fiyat\u0131 80,50 $ gibi belirleyin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon oranlar\u0131n\u0131 kontrol edin\u2014i\u015flem ba\u015f\u0131na %0,5&#8217;in alt\u0131nda hedefleyin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonu izleyin<\/td>\n<td>Kazan\u00e7 tarihleri ve \u00f6nemli haberler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Temett\u00fcleri yeniden yat\u0131r\u0131n<\/td>\n<td>AZN&#8217;nin %1,90 verimi zamanla g\u00fczelce bile\u015fik getiri sa\u011flar<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>\u00dc\u00e7 ayda bir g\u00f6zden ge\u00e7irin<\/td>\n<td>\u015eirket kazan\u00e7 raporlar\u0131na kar\u015f\u0131 performans\u0131 de\u011ferlendirin<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Stratejiyi ayarlay\u0131n<\/td>\n<td>Kan\u0131tlanm\u0131\u015f b\u00fcy\u00fcme onay\u0131yla pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fcn\u00fc art\u0131r\u0131n<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Uzun vadeli tutun<\/td>\n<td>\u0130la\u00e7 hisseleri zamanlamadan \u00e7ok sabr\u0131 \u00f6d\u00fcllendirir<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Pocket Option, yeni ba\u015flayanlar i\u00e7in hisse senedi eri\u015fimini devrim niteli\u011finde de\u011fi\u015ftiriyor:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong>\u2014ger\u00e7ek para ile stratejileri \u00f6nemli risk olmadan test edin<\/li>\n<li><strong>1 dakikal\u0131k KYC s\u00fcreci<\/strong>\u2014herhangi bir resmi kimlik y\u00fckleyin ve hemen ticarete ba\u015flay\u0131n<\/li>\n<li><strong>100+ para \u00e7ekme y\u00f6ntemi<\/strong>\u2014kripto paralar, e-c\u00fczdanlar, banka kartlar\u0131 ve yerel se\u00e7enekler<\/li>\n<li><strong>K\u0131smi hisse al\u0131m\u0131 m\u00fcmk\u00fcn<\/strong>\u2014k\u00fc\u00e7\u00fck sermayeyle bile AZN par\u00e7alar\u0131 sat\u0131n al\u0131n<\/li>\n<li><strong>Ger\u00e7ek zamanl\u0131 piyasa verisi<\/strong>\u2014karma\u015f\u0131kl\u0131k olmadan profesyonel ara\u00e7lar<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, AstraZeneca PLC (AZN) hisselerine ilk yat\u0131r\u0131m\u0131n\u0131z\u0131 basit ve \u00f6\u011fretici hale getirir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te AstraZeneca: \u0130la\u00e7 Devi<\/h2>\n<p>AstraZeneca, 246 milyar $&#8217;\u0131 a\u015fan piyasa de\u011feriyle bir\u00e7ok terap\u00f6tik alanda liderdir. Geleneksel ila\u00e7lar\u0131n \u00f6tesinde, \u015firket yenilik\u00e7i h\u00fccre terapileri ve yapay zeka destekli ila\u00e7 geli\u015ftirmede \u00f6nc\u00fcd\u00fcr. \u0130ngiliz-\u0130sve\u00e7li dev, 130&#8217;dan fazla \u00fclkede faaliyet g\u00f6stermekte ve y\u0131lda yakla\u015f\u0131k 11 milyar $ Ar-Ge harcamas\u0131 yapmaktad\u0131r.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: AstraZeneca&#8217;n\u0131n yeni Virginia \u00fcretim tesisi, ila\u00e7 \u00fcretiminde yapay zeka ve robotik kullanacak\u2014bu, \u015firketin d\u00fcnya \u00e7ap\u0131ndaki en b\u00fcy\u00fck tek yat\u0131r\u0131m\u0131 olacak ve \u00e7al\u0131\u015fanlar\u0131n farkl\u0131 katlar i\u00e7in haftal\u0131k olarak koku se\u00e7ti\u011fi parf\u00fcm p\u00fcsk\u00fcrten asans\u00f6rlere sahip olacak!<\/p>\n<p>Daha fazla e\u011fitim i\u00e7eri\u011fi ve piyasa analizleri i\u00e7in <a href=\"\/blog\">Pocket Option blog<\/a> sayfam\u0131z\u0131 ziyaret edin; karma\u015f\u0131k yat\u0131r\u0131m kavramlar\u0131n\u0131 uygulanabilir stratejilere d\u00f6n\u00fc\u015ft\u00fcr\u00fcyoruz.<\/p>\n"},"faq":[{"question":"AstraZeneca hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, AZN sembol\u00fcn\u00fc aray\u0131n, limit emirleri kullanarak al\u0131m yap\u0131n ve pozisyonunuzu d\u00fczenli olarak izleyin."},{"question":"AstraZeneca'n\u0131n 2025 i\u00e7in fiyat tahmini nedir?","answer":"2025 y\u0131l sonunda hisse fiyat\u0131n\u0131n 86-92 $ aras\u0131nda olmas\u0131 bekleniyor ve bu d\u00f6nemde g\u00fc\u00e7l\u00fc al\u0131m f\u0131rsatlar\u0131 sunuyor."},{"question":"AstraZeneca hisseleri i\u00e7in temel riskler nelerdir?","answer":"D\u00fczenleyici incelemeler, hukuki zorluklar, fiyat bask\u0131lar\u0131 ve klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar AstraZeneca hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131p dolar maliyeti ortalamas\u0131 yapmal\u0131, kazan\u00e7 raporlar\u0131n\u0131 takip etmeli ve uzun vadeli d\u00fc\u015f\u00fcnmelidirler."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi, k\u0131smi hisse al\u0131m\u0131 ve kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ile yeni ba\u015flayanlar i\u00e7in idealdir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"AstraZeneca hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, AZN sembol\u00fcn\u00fc aray\u0131n, limit emirleri kullanarak al\u0131m yap\u0131n ve pozisyonunuzu d\u00fczenli olarak izleyin."},{"question":"AstraZeneca'n\u0131n 2025 i\u00e7in fiyat tahmini nedir?","answer":"2025 y\u0131l sonunda hisse fiyat\u0131n\u0131n 86-92 $ aras\u0131nda olmas\u0131 bekleniyor ve bu d\u00f6nemde g\u00fc\u00e7l\u00fc al\u0131m f\u0131rsatlar\u0131 sunuyor."},{"question":"AstraZeneca hisseleri i\u00e7in temel riskler nelerdir?","answer":"D\u00fczenleyici incelemeler, hukuki zorluklar, fiyat bask\u0131lar\u0131 ve klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar AstraZeneca hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131p dolar maliyeti ortalamas\u0131 yapmal\u0131, kazan\u00e7 raporlar\u0131n\u0131 takip etmeli ve uzun vadeli d\u00fc\u015f\u00fcnmelidirler."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 KYC, \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi, k\u0131smi hisse al\u0131m\u0131 ve kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ile yeni ba\u015flayanlar i\u00e7in idealdir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r - AstraZeneca PLC (AZN) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r - AstraZeneca PLC (AZN) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T17:38:44+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; AstraZeneca PLC (AZN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T17:38:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/\",\"name\":\"AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r - AstraZeneca PLC (AZN) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"datePublished\":\"2025-08-20T17:38:44+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; AstraZeneca PLC (AZN) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r - AstraZeneca PLC (AZN) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/","og_locale":"tr_TR","og_type":"article","og_title":"AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r - AstraZeneca PLC (AZN) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T17:38:44+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; AstraZeneca PLC (AZN) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T17:38:44+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/","name":"AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r - AstraZeneca PLC (AZN) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","datePublished":"2025-08-20T17:38:44+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-astrazeneca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"AstraZeneca PLC (AZN) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; AstraZeneca PLC (AZN) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":342319,"slug":"how-to-buy-astrazeneca","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu AstraZeneca PLC (AZN) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu AstraZeneca PLC (AZN)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-astrazeneca\/"},"pt_AA":{"locale":"pt_AA","id":342320,"slug":"how-to-buy-astrazeneca","post_title":"Como comprar a\u00e7\u00f5es da AstraZeneca PLC (AZN) - Investimento em a\u00e7\u00f5es da AstraZeneca PLC (AZN)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-astrazeneca\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/342317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=342317"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/342317\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334036"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=342317"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=342317"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=342317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}